{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:12:28Z","timestamp":1778267548841,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Talents Training Program of the Seventh People\u2019s Hospital, Shanghai University of Traditional Chinese Medicine","award":["XX2022-03"],"award-info":[{"award-number":["XX2022-03"]}]},{"name":"The Medical Discipline Construction Program of Shanghai Pudong New Area Health Commission (the Key Weak Disciplines Program","award":["PWZbr2022-08"],"award-info":[{"award-number":["PWZbr2022-08"]}]},{"name":"Shanghai Pudong New Area Health and Family Planning Commission Health Science and Technology Project","award":["PW2022A-22"],"award-info":[{"award-number":["PW2022A-22"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04765-z","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:07:05Z","timestamp":1774861625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of DYNLL1 and FGFR2 as potential apoptosis-associated biomarkers in HBV-related hepatocellular carcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Xin","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihan","family":"Bie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiudi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouhong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"2","key":"4765_CR1","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42(2):180\u201397.","journal-title":"Cancer Cell"},{"issue":"13","key":"4765_CR2","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.3390\/cancers16132430","volume":"16","author":"EL Fite","year":"2024","unstructured":"Fite EL, Makary MS. Transarterial chemoembolization treatment paradigms for hepatocellular carcinoma. Cancers (Basel). 2024;16(13):2430.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4765_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jhep.2024.05.017","volume":"81","author":"J Chen","year":"2024","unstructured":"Chen J, Kaya NA, Zhang Y, Kendarsari RI, Sekar K, Lee Chong S, et al. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and \u2018bad apple\u2019 effect on clinical trajectory. J Hepatol. 2024;81(4):667\u201378.","journal-title":"J Hepatol"},{"key":"4765_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1714314","author":"J Li","year":"2026","unstructured":"Li J, Liang YB, Chen XM, Ou ZY, Wang QB, Luo WL, et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front Immunol. 2026. https:\/\/doi.org\/10.3389\/fimmu.2026.1714314.","journal-title":"Front Immunol"},{"key":"4765_CR5","doi-asserted-by":"publisher","DOI":"10.1159\/000549355","author":"J Li","year":"2025","unstructured":"Li J, Liang YB, Wang QB, Luo WL, Chen XM, Lakang Y, et al. Rechallenge with immune checkpoint inhibitors in patients with hepatocellular carcinoma: a narrative review. Liver Cancer. 2025. https:\/\/doi.org\/10.1159\/000549355.","journal-title":"Liver Cancer"},{"key":"4765_CR6","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"QB Wang","year":"2025","unstructured":"Wang QB, Luo WL, Li YK, Li J, Yang ZS, Zhao K, et al. Tumor compression of the hepatic or portal vein predicts the presence of microvascular invasion and satellite nodules in hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2025;12:2055\u201367.","journal-title":"J Hepatocell Carcinoma"},{"key":"4765_CR7","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"WL Luo","year":"2025","unstructured":"Luo WL, Wang QB, Li YK, Liang YB, Li J, Chen XM, et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: a retrospective study. J Hepatocell Carcinoma. 2025;12:2681\u201392.","journal-title":"J Hepatocell Carcinoma"},{"issue":"16","key":"4765_CR8","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/jcmm.17867","volume":"27","author":"L Zheng","year":"2023","unstructured":"Zheng L. Analysis of hepatocellular carcinoma associated with hepatitis B virus. J Cell Mol Med. 2023;27(16):2271\u20137.","journal-title":"J Cell Mol Med"},{"issue":"13","key":"4765_CR9","doi-asserted-by":"publisher","first-page":"11146","DOI":"10.3390\/ijms241311146","volume":"24","author":"VS Patil","year":"2023","unstructured":"Patil VS, Harish DR, Sampat GH, Roy S, Jalalpure SS, Khanal P, et al. System biology investigation revealed lipopolysaccharide and alcohol-induced hepatocellular carcinoma resembled hepatitis B virus immunobiology and pathogenesis. Int J Mol Sci. 2023;24(13):11146.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4765_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/v15040857","volume":"15","author":"K Padarath","year":"2023","unstructured":"Padarath K, Deroubaix A, Kramvis A. The complex role of HBeAg and its precursors in the pathway to hepatocellular carcinoma. Viruses. 2023;15(4):857.","journal-title":"Viruses"},{"key":"4765_CR11","first-page":"1","volume":"151","author":"SG Patel","year":"2021","unstructured":"Patel SG, Murphy CC, Lieu CH, Hampel H. Chapter one-early age onset colorectal cancer. Adv Cancer Res. 2021;151:1\u201337.","journal-title":"Adv Cancer Res"},{"issue":"4","key":"4765_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/hep.28503","volume":"64","author":"DM Tang","year":"2016","unstructured":"Tang DM, Heller T, Koh C. The many faces of positive hepatitis B surface antigen. Hepatology. 2016;64(4):1379\u201381.","journal-title":"Hepatology"},{"issue":"6","key":"4765_CR13","first-page":"8227","volume":"14","author":"D Zhao","year":"2017","unstructured":"Zhao D, Liu Y, Liu X, Li T, Xin Z, Zhu X, et al. Erratum: HBV suppresses thapsigargin-induced apoptosis via inhibiting CHOP expression in hepatocellular carcinoma cells. Oncol Lett. 2017;14(6):8227.","journal-title":"Oncol Lett"},{"issue":"8","key":"4765_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.biopha.2014.09.005","volume":"68","author":"H Gao","year":"2014","unstructured":"Gao H, Liu C. miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC. Biomed Pharmacother. 2014;68(8):943\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4765_CR15","first-page":"499","volume":"11","author":"Y Yano","year":"2003","unstructured":"Yano Y, Hayashi Y, Nakaji M, Nagano H, Seo Y, Ninomiya T, et al. Different apoptotic regulation of TRAIL-caspase pathway in HBV- and HCV-related hepatocellular carcinoma. Int J Mol Med. 2003;11(4):499\u2013504.","journal-title":"Int J Mol Med"},{"issue":"1","key":"4765_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5916-6","volume":"19","author":"J Torresi","year":"2019","unstructured":"Torresi J, Tran BM, Christiansen D, Earnest-Silveira L, Schwab RHM, Vincan E. HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. BMC Cancer. 2019;19(1):707.","journal-title":"BMC Cancer"},{"key":"4765_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6681065","volume":"2023","author":"J Shi","year":"2023","unstructured":"Shi J, Liu Z, Li W, Wang D. Selenium donor inhibited hepatitis B virus associated hepatotoxicity via the apoptosis and ferroptosis pathways. Anal Cell Pathol (Amst). 2023;2023:6681065.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"14","key":"4765_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147867","volume":"25","author":"J Ancer-Rodr\u00edguez","year":"2024","unstructured":"Ancer-Rodr\u00edguez J, Gopar-Cuevas Y, Garc\u00eda-Aguilar K, Ch\u00e1vez-Briones MD, Miranda-Maldonado I, Ancer-Arellano A, et al. Cell proliferation and apoptosis-key players in the lung aging process. Int J Mol Sci. 2024;25(14):7867.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4765_CR19","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/s44319-024-00206-6","volume":"25","author":"TB Beigl","year":"2024","unstructured":"Beigl TB, Paul A, Fellmeth TP, Nguyen D, Barber L, Weller S, et al. BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains. EMBO Rep. 2024;25(9):3896\u2013924.","journal-title":"EMBO Rep"},{"key":"4765_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2024.e00848","volume":"43","author":"SM Abdelnasser","year":"2024","unstructured":"Abdelnasser SM, Abu-Shahba N. Bacillus sonorinses derived exopolysaccharide enhances cell cycle arrest, apoptosis, necrosis, autophagy and COX-2 down regulation in liver cancer cells. Biotechnol Rep (Amst). 2024;43:e00848.","journal-title":"Biotechnol Rep (Amst)"},{"issue":"6","key":"4765_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26(6):1045\u201357.","journal-title":"J Digit Imaging"},{"key":"4765_CR22","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.21037\/tcr-2025-728","volume":"14","author":"J Li","year":"2025","unstructured":"Li J, Huang L, He B, Xie H, Wu Q, Chen L. Identification of lysine crotonylation-driven molecular clusters and immune dysregulation in HBV-related hepatocellular carcinoma via bioinformatics and machine learning. Transl Cancer Res. 2025;14:6248\u201368.","journal-title":"Transl Cancer Res"},{"issue":"130","key":"4765_CR23","first-page":"1","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinf. 2016;54(130):1\u201333.","journal-title":"Curr Protoc Bioinf"},{"key":"4765_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649618","volume":"16","author":"H Liu","year":"2025","unstructured":"Liu H, Sun Z, Wang X, Zhou B, Cha L. Identification of immunogenic cell death signature genes in hepatocellular carcinoma: from single-cell transcriptomics to in vitro mechanistic validation and comprehensive prognostic modeling with hundreds of machine learning algorithms. Front Immunol. 2025;16:1649618.","journal-title":"Front Immunol"},{"issue":"1","key":"4765_CR25","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"3","key":"4765_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.c.31733","volume":"181","author":"J Kiefer","year":"2019","unstructured":"Kiefer J, Hall JG. Gene ontology analysis of arthrogryposis (multiple congenital contractures). Am J Med Genet C Semin Med Genet. 2019;181(3):310\u201326.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"D1","key":"4765_CR27","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353\u201361.","journal-title":"Nucleic Acids Res"},{"key":"4765_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"4765_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"4765_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4765_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-023-00554-z","volume":"15","author":"C Lin","year":"2023","unstructured":"Lin C, Chen Y, Zhang F, Zhu P, Yu L, Chen W. Single-cell RNA sequencing reveals the mediatory role of cancer-associated fibroblast PTN in hepatitis B virus cirrhosis-HCC progression. Gut Pathog. 2023;15(1):26.","journal-title":"Gut Pathog"},{"issue":"21","key":"4765_CR32","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1002\/cncr.34935","volume":"129","author":"Q Chen","year":"2023","unstructured":"Chen Q, Wang X, Zheng Y, Ye T, Liu J, Wang JQ, et al. Cancer-associated fibroblasts contribute to the immunosuppressive landscape and influence the efficacy of the combination therapy of PD-1 inhibitors and antiangiogenic agents in hepatocellular carcinoma. Cancer. 2023;129(21):3405\u201316.","journal-title":"Cancer"},{"issue":"1","key":"4765_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12973-5","volume":"24","author":"Y Shen","year":"2024","unstructured":"Shen Y, Chen J, Zhou Z, Wu J, Hu X, Xu Y, et al. Matrix stiffness-related extracellular matrix signatures and the DYNLL1 protein promote hepatocellular carcinoma progression through the Wnt\/\u03b2-catenin pathway. BMC Cancer. 2024;24(1):1211.","journal-title":"BMC Cancer"},{"issue":"2","key":"4765_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41416-024-02719-2","volume":"131","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li Z, Zhang J, Liu W, Guan S, Zhan Y, et al. DYNLL1 accelerates cell cycle via ILF2\/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. Br J Cancer. 2024;131(2):243\u201357.","journal-title":"Br J Cancer"},{"key":"4765_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104567","volume":"117","author":"C Berkel","year":"2020","unstructured":"Berkel C, Cacan E. DYNLL1 is hypomethylated and upregulated in a tumor stage- and grade-dependent manner and associated with increased mortality in hepatocellular carcinoma. Exp Mol Pathol. 2020;117:104567.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"4765_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2017.10.032","volume":"68","author":"Q Osseman","year":"2018","unstructured":"Osseman Q, Gallucci L, Au S, Cazenave C, Berdance E, Blondot ML, et al. The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids. J Hepatol. 2018;68(3):441\u20138.","journal-title":"J Hepatol"},{"issue":"3","key":"4765_CR37","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2353\/ajpath.2010.090356","volume":"176","author":"T Amann","year":"2010","unstructured":"Amann T, Bataille F, Spruss T, Dettmer K, Wild P, Liedtke C, et al. Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth. Am J Pathol. 2010;176(3):1433\u201342.","journal-title":"Am J Pathol"},{"issue":"1","key":"4765_CR38","first-page":"46","volume":"46","author":"YY Chen","year":"2024","unstructured":"Chen YY, Zhang Q, Gui MH, Feng L, Cao PB, Zhou GQ. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2. Yi Chuan. 2024;46(1):46\u201362.","journal-title":"Yi Chuan"},{"issue":"11","key":"4765_CR39","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-14-0780","volume":"14","author":"JC Jo","year":"2015","unstructured":"Jo JC, Choi EK, Shin JS, Moon JH, Hong SW, Lee HR, et al. Targeting FGFR pathway in human hepatocellular carcinoma: expressing pFGFR and pMET for antitumor activity. Mol Cancer Ther. 2015;14(11):2613\u201322.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"4765_CR40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.21037\/jgo-22-674","volume":"13","author":"W Dong","year":"2022","unstructured":"Dong W, Zhan C. Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma. J Gastrointest Oncol. 2022;13(4):1915\u201326.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"4765_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","volume":"19","author":"M Ringelhan","year":"2018","unstructured":"Ringelhan M, Pfister D, O\u2019Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222\u201332.","journal-title":"Nat Immunol"},{"key":"4765_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, Montali I, Vecchi A, Acerbi G, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849.","journal-title":"Front Immunol"},{"key":"4765_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105031","volume":"101","author":"H Wang","year":"2024","unstructured":"Wang H, Tsung A, Mishra L, Huang H. Regulatory T cell: a double-edged sword from metabolic-dysfunction-associated steatohepatitis to hepatocellular carcinoma. EBioMedicine. 2024;101:105031.","journal-title":"EBioMedicine"},{"issue":"3","key":"4765_CR44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y, Tang L, Guo L, Chen C, Gu S, Zhou Y, et al. CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection. J Hepatol. 2020;72(3):420\u201330.","journal-title":"J Hepatol"},{"issue":"3","key":"4765_CR45","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","volume":"62","author":"OW Yeung","year":"2015","unstructured":"Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol. 2015;62(3):607\u201316.","journal-title":"J Hepatol"},{"issue":"6","key":"4765_CR46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ijc.30553","volume":"140","author":"M Zhu","year":"2017","unstructured":"Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y, et al. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K\/AKT signal pathway. Int J Cancer. 2017;140(6):1346\u201355.","journal-title":"Int J Cancer"},{"issue":"5","key":"4765_CR47","first-page":"1330","volume":"6","author":"Y Xia","year":"2020","unstructured":"Xia Y, Tang G, Chen Y, Wang C, Guo M, Xu T, et al. Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma. Bioact Mater. 2020;6(5):1330\u201340.","journal-title":"Bioact Mater"},{"issue":"3","key":"4765_CR48","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00335-022-09952-1","volume":"33","author":"A Yeermaike","year":"2022","unstructured":"Yeermaike A, Gu P, Liu D, Nadire T. LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma. Mamm Genome. 2022;33(3):525\u201333.","journal-title":"Mamm Genome"},{"key":"4765_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109402","volume":"119","author":"J Zheng","year":"2019","unstructured":"Zheng J, Luo J, Zeng H, Guo L, Shao G. 125i suppressed the Warburg effect viaregulating miR-338\/PFKL axis in hepatocellular carcinoma. Biomed Pharmacother. 2019;119:109402.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4765_CR50","doi-asserted-by":"publisher","first-page":"e70019","DOI":"10.1002\/jgm.70019","volume":"27","author":"S Khalid","year":"2025","unstructured":"Khalid S, Sohail. Natural products as modulators of miRNA in hepatocellular carcinoma: a therapeutic perspective. J Gene Med. 2025;27(5):e70019.","journal-title":"J Gene Med"},{"key":"4765_CR51","doi-asserted-by":"publisher","first-page":"111378","DOI":"10.1016\/j.cellsig.2024.111378","volume":"124","author":"KJ Lv","year":"2024","unstructured":"Lv KJ, Yu SZ, Wang Y, Zhang SR, Li WY, Hou J, et al. Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1. Cell Signal. 2024;124:111378.","journal-title":"Cell Signal"},{"key":"4765_CR52","doi-asserted-by":"publisher","first-page":"1009789","DOI":"10.3389\/fimmu.2022.1009789","volume":"13","author":"L Yu","year":"2022","unstructured":"Yu L, Shen N, Shi Y, Shi X, Fu X, Li S, et al. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data. Cell Signal Front Immunol. 2022;13:1009789.","journal-title":"Cell Signal Front Immunol"},{"issue":"12","key":"4765_CR53","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00251-21","volume":"41","author":"R Liu","year":"2021","unstructured":"Liu R, King A, Tarlinton D, Heierhorst J. The ASCIZ-DYNLL1 axis is essential for TLR4-mediated antibody responses and NF-\u03baB pathway activation. Mol Cell Biol. 2021;41(12):e0025121.","journal-title":"Mol Cell Biol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04765-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04765-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:03:16Z","timestamp":1778266996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04765-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4765"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04765-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of Shanghai Seventh People\u2019s Hospital (Protocol No.: 2024-7th-HIRB-121; Approval Date: December 10, 2024), and and all experiments were conducted in strict accordance with the approved ethical guidelines of the hospital as well as the ethical principles set forth in the Declaration of Helsinki. Written informed consent was obtained from all participating patients or their legally authorized representatives prior to study participation, and all patient samples included in this study were collected with the above-mentioned valid ethical approval and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"713"}}